Kaye Edward M. MD sold STOK
December 1, 2025 · Form 4 insider transaction
Kaye Edward M. MD sold 4,317 shares of Stoke Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
4,317
Price
$0.00
Total value
N/A
InsiderKaye Edward M. MD
RoleDirector
SecurityRestricted Stock Units
Transaction codeM: Option exercise
Transaction dateDecember 1, 2025
Filing dateDecember 3, 2025
Shares owned after0
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock upon settlement.; 21,591 restricted stock units vested on December 1, 2024 and 4,317 vest on December 1, 2025, subject to the reporting person's continued service to the Issuer on each such date.